Picture of Cosmo NV logo

CMHC — Cosmo NV News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareAdventurousMid CapSucker Stock

Brief: Cosmo Full-Year Sees FY Revenue Eur 60 Million To Eur 64 Million

March 26 (Reuters) - Cosmo Pharmaceuticals NV  COPN.S :
    * COSMO FULL-YEAR REPORT 2020: COSMO RETURNS TO OPERATING
PROFIT
    * SEES FY REVENUE EUR 60 MILLION TO EUR 64 MILLION
    * SEES 2021 TOTAL EXPENSES IN RANGE OF EUR 57 - EUR 59
MILLION
    * SEES 2021 OPERATING PROFIT IN RANGE OF EUR 3 - EUR 5
MILLION

Source text for Eikon:  ID:nPn4LQDtfa 
Further company coverage:  COPN.S 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cosmo NV

See all news